Addex Therapeutics Aktie 2985075 / CH0029850754
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
04.12.2025 06:59:45
|
Press Release: Addex Therapeutics Reports 2025 -2-
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements about the intended use of proceeds of the offering. The words "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "project," "potential," "continue," "target" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release, are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, uncertainties related to market conditions. These and other risks and uncertainties are described in greater detail in the section entitled "Risk Factors" in Addex Therapeutics' Annual Report on Form 20-F, prospectus and other filings that Addex Therapeutics may make with the SEC in the future. Any forward-looking statements contained in this press release represent Addex Therapeutics' views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date. Addex Therapeutics explicitly disclaims any obligation to update any forward-looking statements.
(END) Dow Jones Newswires
December 04, 2025 01:00 ET (06:00 GMT)
Nachrichten zu Addex Therapeutics Ltd.
|
17:58 |
Freundlicher Handel in Zürich: SPI zeigt sich schlussendlich fester (finanzen.ch) | |
|
12:26 |
Schwacher Handel: SPI legt den Rückwärtsgang ein (finanzen.ch) | |
|
07.01.26 |
SPI-Wert Addex Therapeutics-Aktie: So viel hätten Anleger mit einem Investment in Addex Therapeutics von vor 5 Jahren verloren (finanzen.ch) | |
|
07.01.26 |
Börse Zürich: SPI zum Handelsstart mit Kursplus (finanzen.ch) | |
|
31.12.25 |
SPI-Wert Addex Therapeutics-Aktie: So viel Verlust wäre bei einem Investment in Addex Therapeutics von vor 3 Jahren angefallen (finanzen.ch) | |
|
24.12.25 |
SPI-Titel Addex Therapeutics-Aktie: So viel hätten Anleger an einem Addex Therapeutics-Investment von vor einem Jahr verloren (finanzen.ch) | |
|
23.12.25 |
Pluszeichen in Zürich: SPI beendet die Sitzung im Plus (finanzen.ch) | |
|
23.12.25 |
Pluszeichen in Zürich: Zum Start des Dienstagshandels Gewinne im SPI (finanzen.ch) |
Analysen zu Addex Therapeutics Ltd.
3 neue Aktien BX Musterportfolio: Lam Research, Safran SA & HSBC Holdings mit François Bloch
Im BX Morningcall werden folgende Aktien analysiert und erklärt – heute mit dem monatlichen Rebalancing:
NEU✅ Lam Research
NEU✅ Safran SA
NEU✅ HSBC Holdings
inklusive Rebalancing:
❌ Quanta Services Inc
❌ AENA
❌ Trane Technologies
https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Aktien in diesem Artikel
| Addex Therapeutics Ltd. | 0.06 | 8.20% |
|
| Addex Therapeutics Ltd (spons. ADRs) | 6.80 | -0.73% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI und DAX schliessen stabil -- Asiens Börsen am Donnerstag letztlich in RotAm heimischen sowie am deutschen Aktienmarkt ging es nur seitwärts. Der Dow legt am Donnerstag zu. An den Märkten in Fernost ging es abwärts.